Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dopamine transporter gene associated with diminished subjective response to amphetamine.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 1 Mar 2005

Lott David C, Kim Soo-Jeong, Cook Edwin H, de Wit Harriet

Abstract excerpt

Individual variability in responses to stimulant drugs may influence risk of stimulant abuse and treatment response. However, the genetic determinants of this variability have yet to be elucidated. The dopamine transporter is an important site of amphetamine action. Therefore, the dopamine transporter gene (DAT1) is a logical candidate gene to study. Using a drug challenge approach, we tested for association...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3' Untranslated Regions
Share to Amphetamine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dopamine Plasma Membrane Transport Proteins

Share to Membrane Glycoproteins

Share to Membrane Transport Proteins

Share to Minisatellite Repeats

Share to Nerve Tissue Proteins

Share to Reference Values

Source

Identifiers

PMID: 15602501
DOI: 10.1038/sj.npp.1300637

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dopamine transporter gene associated with diminished subjective response to amphetamine.PMID 15602501Read ↗

Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers.Semantic proximity Read ↗

Serotonin transporter genotype and acute subjective response to amphetamine.Semantic proximity Read ↗

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.Semantic proximity Read ↗

Norepinephrine transporter gene variation modulates acute response to D-amphetamine.Semantic proximity Read ↗

Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders.Semantic proximity Read ↗

Effect of CYP2D6 genetic variation on patient-reported symptom improvement and side effects among children and adolescents treated with amphetamines.Semantic proximity Read ↗

Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants.Semantic proximity Read ↗

Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol.Semantic proximity Read ↗

Polymorphism in the serotonin transporter gene and moderators of prolactin response to meta-chlorophenylpiperazine in African-American cocaine abusers and controls.Semantic proximity Read ↗

Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.